相关产品推荐更多 >

CD36 Antibody, anti-human, VioGreen™, 100 tests in 1 mL
询价
CD107b Antibody, anti-mouse, FITC, 30 µg in 1 mL
询价
CD20 Antibody, anti-human, PE-Vio® 770, REAfinity™, 30 tests in 60 µL
询价
CD107a (LAMP-1) Antibody, anti-human, APC-Vio® 770, 100 tests in 200 µL
询价
CD45.1 Antibody, anti-mouse, PE-Vio® 615, REAfinity™, 30 µg in 200 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Cytokeratin 19
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REAL822
- 标记物:
PE
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi biotec
- 宿主:
cell line
- 应用范围:
MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 抗体英文名:
Cytokeratin 19 Antibody, anti-human, REAdye_lease™
- 抗体名:
Cytokeratin 19 Antibody, anti-human, REAdye_lease™
- 规格:
200 µL
Detection of Cytokeratin 19+ cellsClone REAL822 is an antibody fragment derived from the full Cytokeratin 19 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL822 recognizes the human Cytokeratin 19, a type I cytokeratin of the keratin family which consists of intermediate filament proteins. They are responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Cytokeratin 19 is the smallest human cytokeratin and is expressed in a large number of epithelial cell types, including many ductal and glandular epithelia. | Cytokeratin 19 has been specified as a marker of tissue differentiation and can be used in the detection of a variety of tumors. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Gao, J. et al. (2014) Serum cytokeratin 19 fragment, CK19-2G2, as a newly identified biomarker for lung cancer. PLoS One 9 (7): e101979. | Saha, S. K. et al. (2018) Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells. Int J Mol Sci 19 (5): .
技术资料暂无技术资料 索取技术资料
文献支持
Cytokeratin 19 Antibody, anti-human, PE, REAdye_lease™, 200 µL
询价





